Talon Resources Targets Ontario Gold Growth After AIM Move and Eagle Lake Acquisition, CEO Says.Watch here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksBunzl Regulatory News (BNZL)

Share Price Information for Bunzl (BNZL)

Share Price is delayed by 15 minutes
Get Live Data
2,652.00    -24.00 (-0.90%)
Bid:
2,652.00
Ask:
2,656.00
Spread: 4.00 (0.151%)
Market Cap: £8.51b
BNZL Live PriceLast checked at - London Stock Exchange

Intraday Bunzl Share Chart

Trading Statement

15 Dec 2021 07:00

RNS Number : 6456V
Bunzl PLC
15 December 2021
 

 

 

15 December 2021

 

BUNZL PRE-CLOSE STATEMENT

 

Bunzl plc, the specialist international distribution and services Group, is updating the market today prior to entering its closed period for the year ending 31 December 2021.

 

The Group's resilient business model is expected to deliver another strong performance in 2021, with underlying revenue expected to demonstrate high single digit growth against 2019. Furthermore, we have continued to benefit from acquisitions completed over the last two years, with 2020 and 2021 representing two of the most acquisitive years in Bunzl's history in terms of committed spend.

 

Group revenue in 2021 is expected to increase year-on-year by approximately 2% at actual exchange rates and by approximately 7% at constant exchange rates, with the impact of acquisitions being similar to underlying revenue growth, and a small negative impact from fewer trading days. At constant exchange rates, underlying revenue growth is expected to reflect a strong recovery in the base business, supported by inflation, partially offset by the anticipated decline in Covid-19 related orders with deflation on certain Covid-19 related products. Group adjusted operating margin is expected to be only slightly ahead of historical levels.

 

Looking ahead, whilst we see continued uncertainties relating to the extent of inflation and the effect of new Covid-19 variants, at constant exchange rates the Group expects revenue in 2022 to be slightly higher than in 2021, driven by the impact of acquisitions completed this year. Continued recovery of the base business is expected to be offset by the further normalisation of sales of Covid-19 related products, albeit these are expected to remain ahead of 2019 levels. Similarly, we expect the continued normalisation of Group operating margins in 2022 to more historical levels, as the mix of sector and product sales returns to more typical levels for the Group.

 

Commenting on today's announcement, Frank van Zanten, Chief Executive Officer of Bunzl, said:

 

"The Group has once again demonstrated the strength and resilience of the Bunzl business model, and the power of our global supply chains and entrepreneurial people who continue to reliably support customers despite supply chain disruptions. Not only has the Group delivered strong underlying growth over the pandemic to date, we have also invested approximately £900m into acquisitions over the last two years, funded by the Group's strong cash flow. Our acquisition pipeline remains active, supported by the strength of our balance sheet. Whilst we expect some continued normalisation of revenue mix in 2022, the performance since the start of the pandemic has only reinforced my confidence in our strategic focus and compounding growth model."

 

Enquiries:

Bunzl plc

Frank van Zanten, Chief Executive Officer

Richard Howes, Chief Financial Officer

Sunita Entwisle, Head of Investor Relations

Tel: +44 (0)20 7725 5000

Tulchan

Martin Robinson

Olivia Peter

Tel: +44 (0)20 7353 4200

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
TSTBLBDDIXBDGBS
Date   Source Headline
1st Jul 20199:30 amRNSTotal Voting Rights
26th Jun 20197:00 amRNSTrading Statement
14th Jun 20195:30 pmRNSDirector/PDMR Shareholding
12th Jun 20195:15 pmRNSDirector/PDMR Shareholding
5th Jun 20191:00 pmRNSDirector/PDMR Shareholding
3rd Jun 20198:00 amRNSTotal Voting Rights
28th May 20197:00 amRNSDirectorate Change
21st May 20194:30 pmRNSDirector/PDMR Shareholding
21st May 20198:00 amRNSAdditional Listing
14th May 20198:00 amRNSAdditional Listing
10th May 20193:30 pmRNSHolding(s) in Company
10th May 20197:00 amRNSDirectorate Change
3rd May 20194:20 pmRNSDirector/PDMR Shareholding
1st May 20193:00 pmRNSBlock listing Interim Review
1st May 201910:20 amRNSTotal Voting Rights
18th Apr 20193:15 pmRNSHolding(s) in Company
17th Apr 20194:00 pmRNSResult of AGM
17th Apr 20197:00 amRNSTrading Statement
11th Apr 20195:25 pmRNSDirector/PDMR Shareholding
3rd Apr 20195:00 pmRNSDirector/PDMR Shareholding
1st Apr 20194:15 pmRNSDirector/PDMR Shareholding
1st Apr 20193:37 pmRNSHolding(s) in Company
1st Apr 20192:30 pmRNSTotal Voting Rights
29th Mar 201911:30 amRNSDirector/PDMR Shareholding
25th Mar 20192:37 pmRNSHolding(s) in Company
14th Mar 20194:40 pmRNSAnnual Financial Report
14th Mar 201912:30 pmRNSDirector/PDMR Shareholding
11th Mar 20195:30 pmRNSDirector/PDMR Shareholding
7th Mar 20195:00 pmRNSDirector/PDMR Shareholding
5th Mar 20194:30 pmRNSDirector/PDMR Shareholding
4th Mar 20195:45 pmRNSDirector/PDMR Shareholding
4th Mar 20195:45 pmRNSDirector/PDMR Shareholding
1st Mar 20193:00 pmRNSDirector/PDMR Shareholding
1st Mar 201911:00 amRNSTotal Voting Rights
25th Feb 201910:00 amRNSDividend Declaration
25th Feb 20197:00 amRNSFinal Results
25th Feb 20197:00 amRNSAcquisition
4th Feb 20196:00 pmRNSDirector/PDMR Shareholding
1st Feb 20199:00 amRNSTotal Voting Rights
9th Jan 20194:30 pmRNSDirector/PDMR Shareholding
3rd Jan 20195:15 pmRNSDirector/PDMR Shareholding
3rd Jan 20197:00 amRNSTotal Voting Rights
13th Dec 20187:00 amRNSTrading Statement
6th Dec 201810:00 amRNSDirector/PDMR Shareholding
6th Dec 20187:00 amRNSDirectorate Change
4th Dec 20184:15 pmRNSDirector/PDMR Shareholding
4th Dec 201812:15 pmRNSDirector/PDMR Shareholding
3rd Dec 20187:00 amRNSTotal Voting Rights
28th Nov 20184:50 pmRNSDirector/PDMR Shareholding
26th Nov 20188:00 amRNSAdditional Listing

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.